Comparative study of the effectiveness of anti-aging cream with hydroquinone and broadband pulsed light in melasma

Abstract

BACKGROUND: Melasma is one of the most common types of hyperpigmentation that significantly impair the quality of life of patients. Despite the availability of effective means and methods of hyperpigmentation therapy, to date there are no clear protocols for the management of patients with melasma.

AIM: of the study was to evaluate the clinical efficacy of anti-aging cream (2% hydroquinone and 0.025% tretinoin) as part of the complex therapy of melasma in women.

MATERIALS AND METHODS: The article presents data on the comparative evaluation of the clinical efficacy of anti-aging cream (2% hydroquinone and 0.025% tretinoin) in the treatment of melasma in 30 women aged 35 to 46 years. The patients were divided into 3 groups: group 1 (n=10) received external therapy with anti-aging cream once a day at night for 3 months, group 2 (n=10) received phototherapy with Lumenis M22 Universal IPL Module 1 time a month for 3 months, group 3 (n=10) ― anti-aging cream + phototherapy with Lumenis M22 Universal IPL 1 time per month for 3 months.

Before the start of therapy, the severity of melasma was determined for all patients based on the calculation of the MASI index (Melasma Area and Severity Index) and the MSS index (Melasma Severity Scale), the level of melanin in the skin was also measured by the method of mexametry, the impact of melasma on the quality of life (QOL) was assessed based on the MELASQoL questionnaire. The effectiveness of therapy was evaluated based on the dynamics of changes in the MASI index and the parameters of the mex before treatment and after 29 days of therapy. Comparison of MELASQoL indicators was carried out before treatment, after 29 days of therapy and 3 months.

RESULTS: Studies have shown that the most pronounced clinical efficacy, namely, a decrease in the severity of melasma, a decrease in the amount of melanin in the skin and an improvement in QOL was observed in 3 group of patients who received combined therapy with anti-aging cream and phototherapy with Lumenis M22 Universal IPL 1 time per month for 3 months. Also, in group 1 patients who received only external therapy with anti-aging cream, there was a significant decrease in the level of melanin in the skin and an improvement in the quality of life after 29 days of therapy and after 3 months of treatment.

CONCLUSIONS: The combination of anti-aging cream with hydroquinone with broadband pulsed lights is an effective method of correcting melasma.

Keywords

melasma / severity of melisma / mexametry / quality of life / cream (2% hydroquinone and 0.025% tretinoin) / phototherapy

References

[1] Krichigina TN, Grushin VN, Belikova IS. Melanocytes: structure, functions, detection methods, role in skin pathology. Bulletin Voronezh State Med University. 2007;6(4):5–16. (In Russ).

[2] Кричигина Т.Н., Грушин В.Н., Беликова И.С., и др. Меланоциты: строение, функции, методы выявления, роль в кожной патологии // Вестник ВГМУ. 2007. Т. 6, № 4. С. 5–16.

[3] Goldsmith LA, Katz SI, Gilcrest BA. Fitzpatrick’s Dermatology in Clinical Practice: in 3 vol. Ed. by N.N. Potekayev, A.N. Lvov. Vol. 1. Moscow: Panfilov Publishing House; 2015. Р. 849–915. (In Russ).

[4] Голдсмит Л.А., Кац С.И., Джилкрест Б.А. Дерматология Фитцпатрика в клинической практике: в 3 т. / под ред. Н.Н. Потекаева, А.Н. Львова. Т. 1. Москва: Издательство Панфилова, 2015. С. 849–915.

[5] Olisova OY, Andreeva EV. Once again about the problem of hyperpigmentation. Russ J Skin and Venereal Diseases. 2014;(2):20–24. (In Russ).

[6] Олисова О.Ю., Андреева Е.В. Еще раз о проблеме гиперпигментации // Российский журнал кожных и венерических болезней. 2014. № 2. С. 20–24.

[7] Kruglova LS, Ikonnikova EV. Skin hyperpigmentation: modern views on etiology and pathogenesis (part 1). Russ J Skin Venereal Diseases. 2017;20(3):178–183. (In Russ). doi: 10.18821/1560-9588-2017-20-3-178-183

[8] Круглова Л.С., Иконникова Е.В. Гиперпигментация кожи: современные взгляды на этиологию и патогенез (часть 1) // Российский журнал кожных и венерических болезней. 2017. Т. 20, № 3. С. 178–183. doi: 10.18821/1560-9588-2017-20-3-178-183

[9] Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):pii E824. doi: 10.3390/ijms17060824

[10] Kwon S.H., Hwang Y.J., Lee S.K., Park K.C. Heterogeneous pathology of melasma and its clinical implications // Int J Mol Sci. 2016. Vol. 17, N 6. Р. piiE824. doi: 10.3390/ijms17060824

[11] Kruglova LS, Ikonnikova EV. Skin hyperpigmentation: a modern view on correction methods (part 2). Russ J Skin Venereal Diseases. 2017;20(4):248–251. (In Russ). doi: 10.18821/1560-9588-2017-20-4-248-251

[12] Круглова Л.С., Иконникова Е.В. Гиперпигментация кожи: современный взгляд на методы коррекции (часть 2) // Российский журнал кожных и венерических болезней. 2017. Т. 20, № 4. С. 248–251. doi: 10.18821/1560-9588-2017-20-4-248-251

[13] Sharuchanova АА. Clinical and laboratory substantiation of differentiated therapy of melasma in women [dissertation abstract]. Moscow; 2019. 29 р.

[14] Шаруханова А.А. Клинико-лабораторное обоснование дифференцированной терапии мелазмы у женщин: Автореф. дис. … канд. мед. наук. Москва, 2019. 29 с.

[15] Heger PG. Children’s dermatology. Transl. from German, ed. A.A. Kubanova, A.N. Lvov. Moscow: BINOM; 2013. Р. 452–476. (In Russ).

[16] Хегер П.Г. Детская дерматология / пер. с нем. под ред. А.А. Кубановой, А.Н. Львова. Москва: БИНОМ, 2013. С. 452–476.

[17] Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol. 2013;169(3):41–56. doi: 10.1111/bjd.12536

[18] Vashi N.A., Kundu R.V. Facial hyperpigmentation: causes and treatment // Br J Dermatol. 2013. Vol. 169, N 3. Р. 41–56. doi: 10.1111/bjd.12536

[19] Kuradovets AA. Development and validation of the Russian version of the MELASQoL-RUS questionnaire for cosmetology practice. Health Education XXI Century. 2018;20(4)79–83. (In Russ). doi: 10.26787/nydha-2226-7425-2018-20-4

[20] Курадовец А.А. Разработка и валидация русскоязычной версии опросника MELASQoL-РУС для косметологической практики // Здоровье и образование в XXI веке. 2018. Т. 20, № 4. С. 79–83. doi: 10.26787/nydha-2226-7425-2018-20-4

Funding

Исследование выполнено при финансовой поддержке компании «Перолайт».The study was carried out with the financial support of the company Perolite.

RIGHTS & PERMISSIONS

Olga A. Sidorenko, Evgeniya P. Opruzhenkova, Ekaterina A. Arkatova